WallStreetZenWallStreetZen

NASDAQ: OCUP
Ocuphire Pharma Inc Earnings & Revenue

OverviewForecastEarnings
DividendOwnership

OCUP past revenue growth

How has OCUP's revenue growth performed historically?
Company
-52.2%
Industry
151.46%
Market
17.61%
OCUP's revenue has grown faster... subscribe to Premium to read more.
Revenue Growth vs Industry Performance
OCUP's revenue has grown faster... subscribe to Premium to read more.
Revenue Growth vs Market Performance

OCUP earnings and revenue history

Current Revenue
$19.0M
Current Earnings
-$10.0M
Current Profit Margin
-52.4%

OCUP Return on Equity

Current Company
-22.3%
Current Industry
-63.5%
Current Market
188%
OCUP's Return on Equity (-22.3%)... subscribe to Premium to read more.
High Return on Equity Performance

Be the first to know when OCUP announces earnings.

OCUP Return on Assets

Current Company
-20.3%
Current Industry
2.9%
OCUP is generating lower Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

OCUP Return on Capital Employed

Current Company
-19.99%
Current Industry
19.5%
OCUP has gotten more efficient... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

OCUP vs Biotech Stocks

TickerRevenueEBITDAEarningsY/Y RevenueY/Y Earnings
OCUP$19.05M-$9.97M-$9.99M+468.69%N/A
MTNB$1.10M-$22.00M-$22.94M+476.30%N/A
SABS$2.24M-$38.13M-$42.19M-8.24%N/A
ICU$0.00-$25.15M-$26.23MN/AN/A
CLNN$654.00k-$42.81M-$49.50M+129.56%N/A
View Top Biotech Stocks

OCUP earnings dates

Next earnings date
May 13, 2024

Ocuphire Pharma Earnings & Revenue FAQ

What were OCUP's earnings last quarter?

On Invalid Date, Ocuphire Pharma (NASDAQ: OCUP) reported Q4 2023 earnings per share (EPS) of -$0.21, up 112.21% year over year. Total Ocuphire Pharma earnings for the quarter were -$4.80 million. In the same quarter last year, Ocuphire Pharma's earnings per share (EPS) was $1.72.

If you're new to stock investing, here's how to buy Ocuphire Pharma stock.

What was OCUP's earnings growth in the past year?

As of Q2 2024, Ocuphire Pharma's earnings has grown year over year. Ocuphire Pharma's earnings in the past year totalled -$9.99 million.

What is OCUP's earnings date?

Ocuphire Pharma's earnings date is Invalid Date. Add OCUP to your watchlist to be reminded of OCUP's next earnings announcement.

What was OCUP's revenue last quarter?

On Invalid Date, Ocuphire Pharma (NASDAQ: OCUP) reported Q4 2023 revenue of $1.69 million up 95.76% year over year. In the same quarter last year, Ocuphire Pharma's revenue was $39.85 million.

What was OCUP's revenue growth in the past year?

As of Q2 2024, Ocuphire Pharma's revenue has grown -52.2% year over year. This is 203.66 percentage points lower than the US Biotechnology industry revenue growth rate of 151.46%. Ocuphire Pharma's revenue in the past year totalled $19.05 million.
©2024 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.